CVS Health Corporation $CVS Shares Purchased by Banco Santander S.A.

Banco Santander S.A. raised its position in CVS Health Corporation (NYSE:CVS) by 249.7% during the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 37,589 shares of the pharmacy operator’s stock after purchasing an additional 26,840 shares during the period. Banco Santander S.A.’s holdings in CVS Health were worth $2,834,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Harbor Capital Advisors Inc. increased its holdings in CVS Health by 72.1% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock valued at $26,000 after acquiring an additional 142 shares in the last quarter. Corundum Trust Company INC acquired a new stake in shares of CVS Health in the third quarter valued at approximately $29,000. Front Row Advisors LLC increased its stake in shares of CVS Health by 436.5% during the 2nd quarter. Front Row Advisors LLC now owns 456 shares of the pharmacy operator’s stock worth $31,000 after purchasing an additional 371 shares in the last quarter. Twin Peaks Wealth Advisors LLC acquired a new position in shares of CVS Health during the 2nd quarter worth approximately $36,000. Finally, SOA Wealth Advisors LLC. lifted its stake in CVS Health by 36.9% in the 3rd quarter. SOA Wealth Advisors LLC. now owns 486 shares of the pharmacy operator’s stock valued at $37,000 after buying an additional 131 shares in the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.

CVS Health Trading Up 2.2%

Shares of CVS stock opened at $79.74 on Friday. CVS Health Corporation has a 1-year low of $58.35 and a 1-year high of $85.15. The firm’s 50-day simple moving average is $78.39 and its 200-day simple moving average is $77.21. The firm has a market cap of $101.44 billion, a P/E ratio of 57.78, a PEG ratio of 0.83 and a beta of 0.50. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.84 and a quick ratio of 0.63.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Tuesday, February 10th. The pharmacy operator reported $1.09 EPS for the quarter, topping the consensus estimate of $1.00 by $0.09. The firm had revenue of $105.69 billion during the quarter, compared to analyst estimates of $103.67 billion. CVS Health had a net margin of 0.44% and a return on equity of 11.31%. CVS Health’s revenue for the quarter was up 8.2% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.19 earnings per share. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. As a group, equities analysts forecast that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, February 2nd. Shareholders of record on Thursday, January 22nd were given a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a yield of 3.3%. The ex-dividend date of this dividend was Thursday, January 22nd. CVS Health’s payout ratio is 192.75%.

Wall Street Analyst Weigh In

Several equities analysts have weighed in on the company. Bank of America dropped their price target on CVS Health from $100.00 to $95.00 and set a “buy” rating for the company in a research report on Tuesday, January 27th. JPMorgan Chase & Co. boosted their target price on shares of CVS Health from $93.00 to $101.00 and gave the company an “overweight” rating in a research note on Wednesday, December 17th. UBS Group restated an “outperform” rating on shares of CVS Health in a report on Wednesday, December 10th. Wells Fargo & Company cut their price objective on shares of CVS Health from $103.00 to $102.00 and set an “overweight” rating for the company in a research report on Thursday, November 13th. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of CVS Health in a research report on Monday, December 29th. Nineteen analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat, CVS Health currently has a consensus rating of “Moderate Buy” and an average target price of $94.91.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.